Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA grants accelerated approvals of Ukoniq for marginal zone lymphoma and follicular lymphoma

Feb. 8, 2021

Korean MFDS grants conditional marketing authorization for Regkirona for COVID-19

Feb. 8, 2021

FDA grants accelerated approval to Tepmetko for metastatic NSCLC with METex14 skipping alterations

Feb. 4, 2021

E.U. grants conditional marketing authorization to AstraZeneca COVID-19 vaccine

Feb. 1, 2021

Rinvoq approved in E.U. for psoriatic arthritis and ankylosing spondylitis

Jan. 26, 2021

Hunterase ICV approved in Japan for MPS II

Jan. 25, 2021

FDA approves Lupkynis oral therapy for lupus nephritis

Jan. 25, 2021

Adlumiz approved in Japan for cancer cachexia

Jan. 22, 2021

FDA approves Verquvo for heart failure

Jan. 20, 2021

FDA approves Darzalex Faspro for newly diagnosed light-chain amyloidosis

Jan. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...